Cortef®: Clinical Trials

4 trials of Cortef®, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 terminated. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Terminated 1
Phase 21Completed 1

Follow Cortef®: new trials by email Literature Review of Cortef® trials Research Report on Cortef®

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Infacort® Versus Cortef® in Healthy Adult Male and Female Subjects
Infacort®, Cortef® - Adrenal Insufficiency
Phase 1CompletedNeurocrine UK Limited512018-04-162026-09-14
A Study of Chronocort® Versus Cortef ® in Healthy Adult Male Subjects
Chronocort®, Cortef® - Adrenal Insufficiency
Phase 1CompletedNeurocrine UK Limited252018-02-192026-09-14
NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma
Prednisone, Vincristine, Daunorubicin - Lymphoblastic Lymphoma
Phase 2CompletedSt. Jude Children's Research Hospital232012-05-252022-06-28
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
EZN-3042, Cytarabine, Doxorubicin - Lymphoblastic Leukemia, Acute, Lymphoblastic Leukemia, Acute, Childhood
Phase 1TerminatedTherapeutic Advances in Childhood Leukemia Consortium62010-08-242024-02-01

Conditions studied

Adrenal Insufficiency (2)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (2)  ·  Leukemia (1)  ·  Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1)  ·  Recurrence (1)

Sponsors

Neurocrine UK Limited (2)  ·  St. Jude Children's Research Hospital (1)  ·  Therapeutic Advances in Childhood Leukemia Consortium (1)

Countries

United Kingdom (2)  ·  United States (2)  ·  Australia (1)

Top investigators

A Koch (2)  ·  Elizabeth Raetz, MD (1)  ·  Hiroto Inaba, MD,PhD (1)  ·  William Carroll, MD (1)

Results publications

PMID 24276047